SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001725160-23-000078
Filing Date
2023-04-28
Accepted
2023-04-28 16:35:29
Documents
23

Document Format Files

Seq Description Document Type Size
1 DEF 14A zntl-20230428.htm   iXBRL DEF 14A 1124885
6 zntl-20230428_g1.jpg GRAPHIC 2890
7 zntl-20230428_g2.jpg GRAPHIC 24189
8 zntl-20230428_g3.jpg GRAPHIC 5173
9 zntl-20230428_g4.jpg GRAPHIC 5757
10 zntl-20230428_g5.jpg GRAPHIC 23785
11 zntl-20230428_g6.jpg GRAPHIC 247009
12 zntl-20230428_g7.jpg GRAPHIC 240789
13 zntl-20230428_g8.gif GRAPHIC 60926
14 zntl-20230428_g9.gif GRAPHIC 57048
  Complete submission text file 0001725160-23-000078.txt   3559214

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT zntl-20230428.xsd EX-101.SCH 4357
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT zntl-20230428_def.xml EX-101.DEF 6841
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT zntl-20230428_lab.xml EX-101.LAB 9054
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT zntl-20230428_pre.xml EX-101.PRE 5453
17 EXTRACTED XBRL INSTANCE DOCUMENT zntl-20230428_htm.xml XML 229469
Mailing Address 1359 BROADWAY, SUITE 801 NEW YORK NY 10018
Business Address 1359 BROADWAY, SUITE 801 NEW YORK NY 10018 (212) 433-3791
Zentalis Pharmaceuticals, Inc. (Filer) CIK: 0001725160 (see all company filings)

IRS No.: 823607803 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39263 | Film No.: 23867210
SIC: 2834 Pharmaceutical Preparations